Overview
Cosmos Health Inc. is a healthcare company headquartered in the United States, primarily engaged in the distribution of pharmaceutical products and healthcare services. The company focuses on the provision and management of cost-effective healthcare supplies and nutritional products globally. A key project for Cosmos Health includes its strategic expansion into the international health market, particularly by leveraging partnerships with local distributors in various countries to enhance the accessibility and affordability of essential medications. Moreover, Cosmos Health has been actively involved in the development and distribution of generic pharmaceuticals and specialty medications, aiming to cater to a broad demographic while emphasizing quality healthcare solutions. Additionally, the company has been advancing in telehealth services, adapting to the growing digital healthcare trend to meet diverse consumer needs efficiently.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Cosmos Health Inc. as of June 30, 2025 is 55.09 MM.
- The operating income for Cosmos Health Inc. as of June 30, 2025 is -14.39 MM.
- The net income for Cosmos Health Inc. as of June 30, 2025 is -15.37 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 55.09 | -14.39 | -15.37 |
2025-03-31 | 53.55 | -14.25 | -15.13 |
2024-12-31 | 54.43 | -15.25 | -16.18 |
2024-09-30 | 56.04 | -20.16 | -20.39 |
2024-06-30 | 56.45 | -20.94 | -21.56 |
2024-03-31 | 55.61 | -21.02 | -19.95 |
2023-12-31 | 53.38 | -21.83 | -18.54 |
2023-09-30 | 49.59 | -15.54 | -15.61 |
2023-06-30 | 48.78 | -12.87 | -14.23 |
2023-03-31 | 49.63 | -10.37 | -14.49 |
2022-12-31 | 50.35 | -7.47 | -13.83 |
2022-09-30 | 54.47 | -0.69 | -4.48 |
2022-06-30 | 56.05 | -1.26 | -4.45 |
2022-03-31 | 57.69 | -2.56 | -5.58 |
2021-12-31 | 56.24 | -4.53 | -7.96 |
2021-09-30 | 56.36 | -3.60 | -7.32 |
2021-06-30 | 57.12 | -1.61 | -4.63 |
2021-03-31 | 55.09 | 0.76 | -0.87 |
2020-12-31 | 55.41 | 2.71 | 0.82 |
2020-09-30 | 50.90 | 2.85 | 1.74 |
Income Statement: EPS
- The earnings per share basic for Cosmos Health Inc. as of June 30, 2025 is -0.89.
- The earnings per share diluted for Cosmos Health Inc. as of June 30, 2025 is -0.89.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | -0.89 | -0.89 |
2025-03-31 | -0.99 | -0.99 |
2024-12-31 | -1.17 | -1.17 |
2024-09-30 | -2.02 | -2.01 |
2024-06-30 | -1.90 | -1.90 |
2024-03-31 | -2.01 | -2.01 |
2023-12-31 | -2.15 | -2.15 |
2023-09-30 | -4.39 | -4.38 |
2023-06-30 | -6.01 | -6.00 |
2023-03-31 | -13.35 | -13.35 |
2022-12-31 | -33.16 | -33.16 |
2022-09-30 | -41.89 | -41.95 |
2022-06-30 | -48.56 | -48.61 |
2022-03-31 | -27.78 | -27.88 |
2021-12-31 | -23.74 | -23.74 |
2021-09-30 | -11.86 | -11.82 |
2021-06-30 | -8.01 | -8.04 |
2021-03-31 | -1.58 | -1.42 |
2020-12-31 | 1.55 | 1.50 |
2020-09-30 | 3.30 | 3.37 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Cosmos Health Inc. as of June 30, 2025 is -4.49 MM.
- The cash from investing activities for Cosmos Health Inc. as of June 30, 2025 is -0.98 MM.
- The cash from financing activities for Cosmos Health Inc. as of June 30, 2025 is 6.47 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -4.49 | -0.98 | 6.47 |
2025-03-31 | -4.49 | -0.93 | 5.40 |
2024-12-31 | -7.72 | -0.80 | 5.05 |
2024-09-30 | -2.93 | -3.15 | 7.72 |
2024-06-30 | -8.19 | -5.07 | 11.38 |
2024-03-31 | -12.70 | -9.15 | 10.66 |
2023-12-31 | -15.64 | -13.76 | 12.69 |
2023-09-30 | -26.91 | -10.35 | 38.97 |
2023-06-30 | -23.91 | -8.31 | 33.63 |
2023-03-31 | -18.88 | -4.60 | 34.38 |
2022-12-31 | -14.87 | -0.02 | 35.05 |
2022-09-30 | -6.10 | -0.06 | 5.27 |
2022-06-30 | -7.60 | -0.98 | 8.02 |
2022-03-31 | -8.77 | -0.74 | 9.80 |
2021-12-31 | -7.10 | -0.83 | 7.27 |
2021-09-30 | -6.71 | -0.84 | 7.95 |
2021-06-30 | -8.15 | -0.04 | 6.88 |
2021-03-31 | -11.02 | -0.07 | 10.45 |
2020-12-31 | -11.50 | -0.12 | 12.46 |
2020-09-30 | -11.56 | -0.14 | 11.11 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- The p/e for Cosmos Health Inc. as of June 30, 2025 is -0.75.
- The p/book for Cosmos Health Inc. as of June 30, 2025 is 0.44.
- The p/tbv for Cosmos Health Inc. as of June 30, 2025 is 0.63.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -0.75 | 0.44 | 0.63 |
2025-03-31 | -0.46 | 0.27 | 0.35 |
2024-12-31 | -0.69 | 0.40 | 0.52 |
2024-09-30 | -0.73 | 0.49 | 0.65 |
2024-06-30 | -0.73 | ||
2024-03-31 | 0.27 | 0.30 | |
2023-12-31 | -1.21 | 0.42 | 0.47 |
2023-09-30 | -1.44 | 0.46 | 0.51 |
2023-06-30 | -2.19 | 0.71 | 0.73 |
2023-03-31 | -8.32 | 7.23 | |
2022-12-31 | -10.75 | 9.34 | 10.77 |
2022-09-30 | 0.65 | 0.72 | |
2022-06-30 | 0.65 | 0.68 | |
2022-03-31 | -5.01 | 7.88 | 8.85 |
2021-12-31 | -7.98 | 12.56 | 14.10 |
2021-09-30 | -17.06 | 205.18 | 462.90 |
2021-06-30 | |||
2021-03-31 | -18.25 | -5.66 | -5.24 |
2020-12-31 | 16.08 | -3.17 | -3.01 |
2020-09-30 | 7.44 | -2.72 | -2.59 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
- The ebit/ev for Cosmos Health Inc. as of June 30, 2025 is -0.66.
- The ebit (3y)/ev for Cosmos Health Inc. as of June 30, 2025 is -0.73.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.66 | -0.73 |
2025-03-31 | -1.24 | -1.10 |
2024-12-31 | -0.97 | -0.82 |
2024-09-30 | -0.82 | -0.51 |
2024-06-30 | -1.34 | -1.00 |
2024-03-31 | -0.78 | -0.62 |
2023-12-31 | -0.58 | -0.33 |
2023-09-30 | -0.50 | -0.27 |
2023-06-30 | -0.49 | -0.26 |
2023-03-31 | -0.06 | -0.05 |
2022-12-31 | -0.05 | -0.04 |
2022-09-30 | -0.13 | -0.10 |
2022-06-30 | -0.15 | -0.10 |
2022-03-31 | -0.11 | -0.06 |
2021-12-31 | -0.08 | -0.03 |
2021-09-30 | -0.04 | -0.05 |
2021-06-30 | ||
2021-03-31 | -0.02 | -0.08 |
2020-12-31 | 0.03 | -0.08 |
2020-09-30 | 0.04 | -0.10 |
Management Effectiveness
- The roa for Cosmos Health Inc. as of June 30, 2025 is -0.25.
- The roe for Cosmos Health Inc. as of June 30, 2025 is -0.47.
- The roic for Cosmos Health Inc. as of June 30, 2025 is -0.39.
- The croic for Cosmos Health Inc. as of June 30, 2025 is -0.00.
- The ocroic for Cosmos Health Inc. as of June 30, 2025 is -0.12.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-06-30 | -0.25 | -0.47 | -0.39 | -0.00 | -0.12 |
2025-03-31 | -0.33 | -0.59 | -0.44 | 0.02 | -0.06 |
2024-12-31 | -0.31 | -0.57 | -0.44 | 0.02 | -0.06 |
2024-09-30 | -0.30 | -0.48 | -0.49 | -0.04 | -0.19 |
2024-06-30 | -0.23 | -0.35 | |||
2024-03-31 | -0.23 | -0.39 | -0.28 | 0.04 | -0.49 |
2023-12-31 | -0.34 | -3.03 | -0.28 | 0.04 | -0.49 |
2023-09-30 | -0.30 | -1.75 | -0.27 | 0.03 | -0.45 |
2023-06-30 | -0.30 | -1.78 | -0.27 | 0.03 | -0.45 |
2023-03-31 | -0.09 | -0.42 | -0.21 | 0.16 | -0.27 |
2022-12-31 | -0.09 | -0.96 | -0.15 | -0.02 | -0.20 |
2022-09-30 | -0.09 | -0.96 | -0.15 | -0.02 | -0.21 |
2022-06-30 | -0.12 | -14.52 | -0.14 | -0.01 | -0.24 |
2022-03-31 | -0.18 | -0.14 | 0.01 | -0.22 | |
2021-12-31 | -0.17 | -0.24 | -0.01 | -0.20 | |
2021-09-30 | -0.19 | -0.22 | -0.00 | -0.27 | |
2021-06-30 | -0.14 | -0.35 | -0.12 | -0.61 | |
2021-03-31 | -0.04 | -0.03 | -0.02 | -0.40 | |
2020-12-31 | 0.03 | 0.03 | 0.02 | -0.39 | |
2020-09-30 | 0.08 | 0.06 | -0.00 | -0.42 |
Gross Margins
- The gross margin for Cosmos Health Inc. as of June 30, 2025 is 0.09.
- The net margin for Cosmos Health Inc. as of June 30, 2025 is -0.28.
- The operating margin for Cosmos Health Inc. as of June 30, 2025 is -0.27.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-06-30 | 0.09 | -0.28 | -0.27 |
2025-03-31 | 0.08 | -0.36 | -0.36 |
2024-12-31 | 0.08 | -0.36 | -0.36 |
2024-09-30 | 0.08 | -0.38 | -0.37 |
2024-06-30 | 0.07 | -0.31 | -0.31 |
2024-03-31 | 0.07 | -0.31 | -0.31 |
2023-12-31 | 0.07 | -0.31 | -0.31 |
2023-09-30 | 0.08 | -0.29 | -0.26 |
2023-06-30 | 0.10 | -0.29 | -0.26 |
2023-03-31 | 0.16 | -0.29 | -0.21 |
2022-12-31 | 0.16 | -0.08 | -0.01 |
2022-09-30 | 0.16 | -0.08 | -0.01 |
2022-06-30 | 0.16 | -0.08 | -0.02 |
2022-03-31 | 0.13 | -0.10 | -0.04 |
2021-12-31 | 0.13 | -0.14 | -0.08 |
2021-09-30 | 0.13 | -0.13 | -0.06 |
2021-06-30 | 0.13 | -0.08 | -0.03 |
2021-03-31 | 0.14 | -0.02 | 0.01 |
2020-12-31 | 0.15 | 0.01 | 0.05 |
2020-09-30 | 0.15 | 0.03 | 0.06 |
Identifiers and Descriptors
Central Index Key (CIK) | 1474167 |
Industry Groups
SIC 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries |